Results 181 to 190 of about 6,390 (207)
Some of the next articles are maybe not open access.

POLYPOIDAL CHOROIDAL VASCULOPATHY IN ITALY

Retina, 2001
To report on the frequency and clinical features of polypoidal choroidal vasculopathy (PCV) in a consecutive series of elderly Italian patients presenting with macular exudation.The authors conducted a retrospective study on a series of 194 consecutive patients 50 years or older with newly diagnosed exudative maculopathy and the presumed diagnosis of ...
B, Scassellati-Sforzolini   +5 more
openaire   +2 more sources

Polypoidal choroidal vasculopathy: natural history

American Journal of Ophthalmology, 2002
The present study was performed to clarify the long-term natural history of polypoidal choroidal vasculopathy (PCV).Prospective, consecutive observational case series.Fourteen eyes of 12 consecutive patients with PCV were prospectively followed in our clinic for at least 2 years without any treatment after a first visit to the clinic between February ...
Masanobu, Uyama   +7 more
openaire   +2 more sources

Polypoidal Choroidal Vasculopathy

2022
Shinji Ono, Yasuo Yanagi
openaire   +1 more source

Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome

Seminars in Immunopathology, 2022
Jason S Knight, Yogendra Kanthi
exaly  

Polypoidal Choroidal Vasculopathy

Optometry - Journal of the American Optometric Association, 2010
Gloria H. Chung   +3 more
openaire   +1 more source

Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients

Journal of Allergy and Clinical Immunology: in Practice, 2021
Marie-Louise Frémond   +2 more
exaly  

Polypoidal Choroidal Vasculopathy

2009
Gabriel Coscas   +4 more
openaire   +2 more sources

COVID-19 Vasculopathy: Mounting Evidence for an Indirect Mechanism of Endothelial Injury

American Journal of Pathology, 2021
Roberto F Nicosia   +2 more
exaly  

Brolucizumab in polypoidal choroidal vasculopathy

Expert Opinion on Biological Therapy, 2022
Ashish Sharma   +5 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy